Detailed Coverage

Sumitomo Chemical India Reports 20.42% Profit Growth in Q1 FY27

Sumitomo Chemical India reported a standalone profit of ₹216.53 crore for the quarter ending June 30, 2026, a significant increase of 20.42% from ₹179.81 crore in the same quarter last year. Revenue from operations stood at ₹1,054.08 crore, a marginal increase of 0.57% from ₹1,048.07 crore year-on-year.

Reader Takeaway: Stable revenue and profit growth driven by one-time gain; regulatory risk looms.

What just happened

Sumitomo Chemical India's standalone profit for the first quarter of fiscal year 2027 (ending June 30, 2026) rose by 20.42% to ₹216.53 crore. This was accompanied by a modest 0.57% increase in standalone revenue, which reached ₹1,054.08 crore. The company also recorded an exceptional income of ₹26.90 crore from an insurance claim related to a fire incident at its Bhavnagar plant in FY2022-2023.

Why this matters

The profit growth is notable, but investors must consider the ₹26.90 crore insurance payout which contributed to the bottom line. While the company's revenue shows stability, the core operational performance needs to be assessed alongside this one-time gain. The agro-chemical business's seasonality, tied to monsoons, is a key factor for understanding longer-term performance.

The backstory

Sumitomo Chemical India operates primarily in the agro-chemicals segment. The business is inherently seasonal and dependent on climatic conditions like the monsoon. The company faced a fire incident at its Bhavnagar plant during the financial year 2022-2023, for which it has now received an insurance claim.

What changes now

This quarterly result provides a snapshot of the company's financial health. The inclusion of the insurance claim means the reported profit is elevated for this period. Investors will be looking for sustained operational performance in subsequent quarters, factoring in the business's seasonal cycles.

Risks to watch

A significant watch point is the regulatory risk associated with Glyphosate, a key product. The Central Government's notification regarding its use is currently sub-judice in the Delhi High Court. Any adverse ruling could impact an important revenue stream for the company.

Peer comparison

(No peer comparison data available in the filing)

Context metrics (time-bound)

Standalone Revenue (Q1 June 2026): ₹1,054.08 crore
Standalone Revenue (Q1 June 2025): ₹1,048.07 crore
Standalone Profit (Q1 June 2026): ₹216.53 crore
Standalone Profit (Q1 June 2025): ₹179.81 crore
Exceptional Income (Insurance Claim): ₹26.90 crore
Basic and Diluted EPS (Q1 June 2026): ₹4.34

What to track next

Investors should closely monitor the upcoming quarterly results to gauge the impact of seasonal factors and the potential outcome of the Glyphosate regulatory proceedings. Understanding the underlying operational profitability without exceptional items will be key.